Skip to main content

Table 2 Treatment characteristics of the enrolled patients

From: Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy

  No. of patients
  Stage IIIA Stage IIIB Stage IV
CBDCA + PAC + TRT 6 14 0
CBDCA + PAC 0 13 56
CBDCA + GEM 0 3 14
CDDP + GEM 0 0 2
  1. Abbreviations: TRT, thoracic radiotherapy